Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Jonesboro. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Jonesboro at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits wit
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this non-small cell lung cancer clinical trial in Jonesboro, AR
If you're searching for non-small cell lung cancer treatment options in Jonesboro, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Jonesboro research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.